Pancreatic cancer drug to remain available on the Welsh NHS - but not in England

Status
Not open for further replies.
Northerner

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
A drug which provides hope to pancreatic cancer patients will continue to be made available on the Welsh NHS.

The National Institute for Health and Care Excellence (NICE) decided not to recommendAbraxane for use within the NHS in England or Wales in October 2015.

But in light of a “clear clinical need” for 400 to 500 pancreatic cancer patients in Wales, the Welsh Government has reached an agreement with Abraxane’s manufacturer Celgene to secure continued access for Welsh patients.

http://www.walesonline.co.uk/news/health/pancreatic-cancer-drug-remain-available-11056335
 
Trouble is it's still really difficult to diagnose. But hope is very valuable stuff.
 
Status
Not open for further replies.
Back
Top